tradingkey.logo
tradingkey.logo
Search

Stryker Corp

SYK
Add to Watchlist
319.210USD
+9.970+3.22%
Close 07-23 16:00ETQuotes delayed by 15 min
122.10BMarket Cap
36.58P/E TTM

Stryker Corp

319.210
+9.970+3.22%
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+3.22%

5 Days

-3.62%

1 Month

+2.97%

6 Months

-10.09%

Year to Date

-9.18%

1 Year

-20.38%

Key Figures
310.000Open
319.380High
2.51MVolume
36.58P/E TTM
18.86P/E Dynamic
3.440Dividend TTM
0.66%Turnover Ratio
309.240Prev. Close
306.900Low
442.08MTurnover
40.79P/E Static
5.45P/B
1.08%Div Yield TTM
7.23%ROA
404.87052wk High
1.26Volume Ratio
2.99BNet Profit
382.50MShares
8.7252EPS TTM
0.79Beta
15.20%ROE
281.00052wk Low
4.04%Amplitude
60.58%Gross Margin
122.10BMarket Cap
-1.02Reward/Risk
1.38%Risk Rate

TradingKey Stock Score of Stryker Corp

Currency: USD Updated: 2026-07-23

Key Insights

Stryker Corp's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 15 out of 200 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 387.46.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Stryker Corp's Score

Industry at a Glance

Industry Ranking
15 / 200
Overall Ranking
60 / 4547
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

43°C

Very Low
Very High
Neutral

Stryker Corp Highlights

StrengthsRisks
Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 22.53% year-on-year.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 41.30%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 41.30%.
Undervalued
The company’s latest PE is 36.56, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 312.34M shares, decreasing 1.14% quarter-over-quarter.
Held by Jerome Dodson | PARNX
Star Investor Jerome Dodson | PARNX holds 2.19M shares of this stock.

Analyst Rating

Based on 30 analysts
Buy
Current Rating
387.462
Target Price
+23.17%
Upside Space

Stryker Corp News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 30 analysts
Buy
Current Rating
387.462
Target Price
+23.17%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Stryker Corp
SYK
30
Medtronic PLC
MDT
34
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
Medline Ord Shs Class A
MDLN
28
1
2
3
...
22

Indicators

Indicators
Sell(2)
Neutral(4)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
-3.129
Neutral
RSI(14)
50.488
Neutral
STOCH(KDJ)(9,3,3)
32.688
Neutral
ATR(14)
10.147
High Vlolatility
CCI(14)
-72.948
Neutral
Williams %R
58.001
Sell
TRIX(12,20)
0.103
Sell
StochRSI(14)
100.000
Buy
Moving Average
Sell(4)
Neutral(0)
Buy(2)
Indicators
Value
Direction
MA5
316.360
Buy
MA10
320.174
Sell
MA20
322.214
Sell
MA50
313.197
Buy
MA100
323.442
Sell
MA200
344.029
Sell

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Stryker Corp Info

Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
Ticker SymbolSYK
CompanyStryker Corp
CEOLobo (Kevin A)
Websitehttps://www.stryker.com/

Shareholders

Shareholders
Shareholders
Proportion
Vanguard Capital Management, LLC
5.84%
Brown (John W)
5.23%
BlackRock Institutional Trust Company, N.A.
4.39%
Greenleaf Trust
4.16%
State Street Investment Management (US)
3.98%
Other
76.40%

FAQs

What is the current price of Stryker Corp (SYK)?

The current price of Stryker Corp (SYK) is 319.21.

What is the symbol of Stryker Corp?

The ticker symbol of Stryker Corp is SYK.

What is the 52-week high of Stryker Corp?

The 52-week high of Stryker Corp is 404.87.

What is the 52-week low of Stryker Corp?

The 52-week low of Stryker Corp is 281.00.

What is the market capitalization of Stryker Corp?

The market capitalization of Stryker Corp is 122.10B.

Is Stryker Corp (SYK) currently rated as Buy, Hold, or Sell?

According to analysts, Stryker Corp (SYK) has an overall rating of Buy, with a price target of 387.46.

What is the Earnings Per Share (EPS TTM) of Stryker Corp (SYK)?

The Earnings Per Share (EPS TTM) of Stryker Corp (SYK) is 8.49.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.